| James Gregory Yost, MD | |
|
6250 Regional Plz, Suite 1010, Abilene, TX 79606-5262 | |
| (325) 428-5500 | |
| (325) 428-5519 |
| Full Name | James Gregory Yost |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 38 Years |
| Location | 6250 Regional Plz, Abilene, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659443208 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | H2917 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hendrick Medical Center | Abilene, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hendrick Provider Network | 9739162181 | 231 |
News Archive
An increasing number of Ugandan men are seeking circumcisions in response to increasing evidence that the procedure could reduce a man's risk of contracting HIV, the AP/Advocate reports
ACT Biotech Inc., a privately held biotechnology company based in San Francisco, California, today announced positive interim data from a Phase 2 trial of the Company's lead oral kinase inhibitor, Telatinib, for the first-line treatment of patients with advanced gastric cancer. This proof-of-concept, multi-center, open label trial was designed to test the efficacy and safety of full-dose Telatinib, administered continuously, as a first-line treatment in combination with a standard regimen of capecitabine and cisplatin in US and European patients.
Northwestern Medicine scientists have discovered a new cause of Parkinson's disease - mutations in a gene called TMEM230. This appears to be the third gene definitively linked to confirmed cases of the common movement disorder.
As more people in China adopt Western diets and lifestyles, many are developing a cluster of cardiovascular disease risk factors, according to a new study in the April 18, 2006, issue of the Journal of the American College of Cardiology.
Kathy Donohue, R.N. of Independence Blue Cross (IBC), will present on a patient safety panel as part of the Pennsylvania State Nurses Summit this morning at 10:30 a.m. at DeSales University in the Lehigh Valley.
› Verified 3 days ago
| Entity Name | Hendrick Provider Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396961322 PECOS PAC ID: 9739162181 Enrollment ID: O20040609001047 |
News Archive
An increasing number of Ugandan men are seeking circumcisions in response to increasing evidence that the procedure could reduce a man's risk of contracting HIV, the AP/Advocate reports
ACT Biotech Inc., a privately held biotechnology company based in San Francisco, California, today announced positive interim data from a Phase 2 trial of the Company's lead oral kinase inhibitor, Telatinib, for the first-line treatment of patients with advanced gastric cancer. This proof-of-concept, multi-center, open label trial was designed to test the efficacy and safety of full-dose Telatinib, administered continuously, as a first-line treatment in combination with a standard regimen of capecitabine and cisplatin in US and European patients.
Northwestern Medicine scientists have discovered a new cause of Parkinson's disease - mutations in a gene called TMEM230. This appears to be the third gene definitively linked to confirmed cases of the common movement disorder.
As more people in China adopt Western diets and lifestyles, many are developing a cluster of cardiovascular disease risk factors, according to a new study in the April 18, 2006, issue of the Journal of the American College of Cardiology.
Kathy Donohue, R.N. of Independence Blue Cross (IBC), will present on a patient safety panel as part of the Pennsylvania State Nurses Summit this morning at 10:30 a.m. at DeSales University in the Lehigh Valley.
› Verified 3 days ago
| Entity Name | Hpn Physician Billing, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538656186 PECOS PAC ID: 7315357191 Enrollment ID: O20201105002661 |
News Archive
An increasing number of Ugandan men are seeking circumcisions in response to increasing evidence that the procedure could reduce a man's risk of contracting HIV, the AP/Advocate reports
ACT Biotech Inc., a privately held biotechnology company based in San Francisco, California, today announced positive interim data from a Phase 2 trial of the Company's lead oral kinase inhibitor, Telatinib, for the first-line treatment of patients with advanced gastric cancer. This proof-of-concept, multi-center, open label trial was designed to test the efficacy and safety of full-dose Telatinib, administered continuously, as a first-line treatment in combination with a standard regimen of capecitabine and cisplatin in US and European patients.
Northwestern Medicine scientists have discovered a new cause of Parkinson's disease - mutations in a gene called TMEM230. This appears to be the third gene definitively linked to confirmed cases of the common movement disorder.
As more people in China adopt Western diets and lifestyles, many are developing a cluster of cardiovascular disease risk factors, according to a new study in the April 18, 2006, issue of the Journal of the American College of Cardiology.
Kathy Donohue, R.N. of Independence Blue Cross (IBC), will present on a patient safety panel as part of the Pennsylvania State Nurses Summit this morning at 10:30 a.m. at DeSales University in the Lehigh Valley.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James Gregory Yost, MD 1680 Antilley Rd, Suite 110, Abilene, TX 79606-5267 Ph: (325) 428-5600 | James Gregory Yost, MD 6250 Regional Plz, Suite 1010, Abilene, TX 79606-5262 Ph: (325) 428-5500 |
News Archive
An increasing number of Ugandan men are seeking circumcisions in response to increasing evidence that the procedure could reduce a man's risk of contracting HIV, the AP/Advocate reports
ACT Biotech Inc., a privately held biotechnology company based in San Francisco, California, today announced positive interim data from a Phase 2 trial of the Company's lead oral kinase inhibitor, Telatinib, for the first-line treatment of patients with advanced gastric cancer. This proof-of-concept, multi-center, open label trial was designed to test the efficacy and safety of full-dose Telatinib, administered continuously, as a first-line treatment in combination with a standard regimen of capecitabine and cisplatin in US and European patients.
Northwestern Medicine scientists have discovered a new cause of Parkinson's disease - mutations in a gene called TMEM230. This appears to be the third gene definitively linked to confirmed cases of the common movement disorder.
As more people in China adopt Western diets and lifestyles, many are developing a cluster of cardiovascular disease risk factors, according to a new study in the April 18, 2006, issue of the Journal of the American College of Cardiology.
Kathy Donohue, R.N. of Independence Blue Cross (IBC), will present on a patient safety panel as part of the Pennsylvania State Nurses Summit this morning at 10:30 a.m. at DeSales University in the Lehigh Valley.
› Verified 3 days ago
Dr. Trey Dennis Durdin, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1904 Pine St Ste 3a, Abilene, TX 79601 Phone: 325-670-6180 Fax: 833-437-1278 | |
Dr. Vernon Williams, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1100 N 19th St, Suite 4d, Abilene, TX 79601 Phone: 325-676-8555 | |
Kathryn S Norton, M. D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1100 N 19th St, Suite 4g, Abilene, TX 79601 Phone: 325-670-4620 Fax: 325-670-4624 | |
Benton Lee Brown, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1680 Antilley Rd, Ste 110, Abilene, TX 79606 Phone: 325-428-5600 Fax: 325-428-5609 | |
Dr. Gary David Walker, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 1100 N 19th St, Suite 4d, Abilene, TX 79601 Phone: 325-676-8555 Fax: 325-676-1026 | |
Katherine Holden Rinard, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1924 Pine St, Suite 505, Abilene, TX 79601 Phone: 325-670-6180 | |
Dr. Lashondria Renee Camp, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1924 Pine St, Suite 501, Abilene, TX 79601 Phone: 325-670-4333 Fax: 325-670-4336 |